Delivra Health Brands Inc. (TSX-V:DHB) earlier this week highlighted the international expansion of its Dream Water Sleep Gummies, announcing entry into the Middle East market.
The company said the move builds on the prior success of its Dream Water sleep shot in the region, where strong distributor relationships helped establish early market traction.
The gummies feature Delivra’s proprietary sleep formulation — GABA, melatonin and 5-HTP — now delivered in a format that Davey said consumers had been asking for. “We’ve been able to bring it to the market quite successfully,” he told Proactive.
The company noted that distribution of its sleep products now spans all North American airports, supporting its broader strategy of growing across channels, customer bases and geographies.
Delivra said innovation will continue to play a key role in expansion, with additional product developments planned. “The success of this innovation has allowed us to expand into markets, channels and customers,” Davey said.
Looking ahead, the company believes the sleep aid market remains substantial. Davey cited data indicating that 70% of the population struggles with sleep at some point, and stated: “100% of the people sleep at night. So there’s a 100% marketplace.”
Delivra said it remains focused on providing safe sleep solutions and expects further opportunities across global markets.